Radioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular Carcinoma.

ABSTRACT:

Purpose

To identify baseline characteristics and long-term prognostic factors in non-transplant patients with unresectable hepatocellular carcinoma (HCC) who had prolonged survival after treatment with yttrium-90 radioembolization (Y90).

Materials and methods

Sixty-seven "Super Survivors" (defined as ≥ 3-year survival after Y90) were identified within our 1000-patient Y90 database (2003-2017). Baseline imaging and follow-up occurred at 1 month and every 3 months thereafter. Overall survival (OS) was calculated with Kaplan-Meier estimates with log-rank test in subgroups: Child-Pugh (CP) score, distribution of disease, portal vein thrombus (PVT), and technique (segmental vs lobar Y90).

Results

Median age 69.5 years (range 45-94 years); 69% male; 60% solitary HCC; 79% un

SUBMITTER: Gordon AC 

PROVIDER: S-EPMC6128743 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature